Portland, OR -- (SBWire) -- 11/09/2017 --DNA diagnostics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $19 billion by 2020, registering a CAGR of 9.8% during the period 2014-2020. The potential to provide accurate diagnosis and cost effectiveness over alternative diagnostic techniques are factors which supplement the growth of the DNA diagnostics market.
"Next generation sequencing not only reduces the cost of sequencing, but increases the throughput as well; it could thus help in bridging the gaps in traditional and personalized medications", adds the analyst. This makes it a promising investment opportunity for key players. Illumina Inc.'s new cost-effective genome machine HiSeq X Ten -the world's first DNA crunching supercomputer- is leading to a significant reduction in the price of sequencing a human genome.
Get the sample copy of this report: https://www.alliedmarketresearch.com/request-sample/298
AMR analysis suggests that the tremendous potential of novel DNA diagnostic technologies and the probability of them being adopted in personalized medicines has not only reduced the expenditure in diagnostic procedures but has also helped in increasing the efficiency of chronic disease identification. Furthermore, the emergence of personalized medicines and the rising number of initiatives vis--vis product development and clinical trials forkey players has laid the groundwork for DNA diagnostics technologies.
Make a purchase enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/298
Market analysis in terms of geography suggests that developed economies would retain their dominance in the market. This could be attributed to the early adoption of the technology due to potential reduction offered by DNA diagnostic to their high healthcare expenditure. However, developing economies, such as in Asia-Pacific, will significantly influence the DNA diagnostic market during the extended forecast period (2020-2025), largely due to potential growth in per capita healthcare expenditure and very large undiagnosed population.
MARKET SEGMENTATION:
MARKET BY PRODUCT TYPE
-Instruments
-Reagents
-Service & Software
MARKET BY TECHNOLOGY
-PCR
-Microarray
-In-situ Hybridization
-Sequencing Technology
-Mass Spectrometry
-Others
MARKET BY APPLICATION
-Oncology
-Infectious Disease
-Myogenic Disorder
-Clinical Diagnostic Confirmation
-Prenatal Diagnostics
-Pre-implantation Diagnostics
-Others
MARKET BY END USERS
-Point of Care
-Diagnostic Center
-Self Testing/OTC
MARKET BY GEOGRAPHY
-North America
-Asia Pacific
-Europe
-LAMEA
DNA Diagnostics Market: Revenue, Type and Applications Forecast to 2020
The report breaks the market into segments based on product type, technology, application, end users and geography.